Addentax (ATXG) Common Equity (2015 - 2025)

Addentax (ATXG) has 11 years of Common Equity data on file, last reported at $21.6 million in Q4 2025.

• Common Equity for Q4 2025 came in at $21.6 million, down 9.16% year-over-year; the trailing twelve-month figure through Dec 2025 was $21.6 million (down 9.16% YoY), and the FY2025 annual result was $21.7 million, down 16.57% from the prior year.
• Common Equity declined to $21.6 million in Q4 2025 per ATXG's latest filing, from $25.9 million in the prior quarter.
• Over five years, Common Equity peaked at $26.8 million in Q3 2023 and troughed at -$81498.0 in Q1 2021.
• A 5-year average of $17.0 million and a median of $23.4 million in 2022 frame the typical range for Common Equity.
• On a YoY basis, Common Equity climbed as much as 493105.27% in 2022 and fell as far as 115.83% in 2022.
• A 5-year view of Common Equity shows it stood at -$21808.0 in 2021, then jumped by 105143.82% to $22.9 million in 2022, then advanced by 5.83% to $24.2 million in 2023, then declined by 1.78% to $23.8 million in 2024, then decreased by 9.16% to $21.6 million in 2025.
• Business Quant data shows ATXG's Common Equity at $21.6 million in Q4 2025, $25.9 million in Q3 2025, and $25.2 million in Q2 2025.